GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Pubmed ID: 34844716
Publication Date: 2021/10/23

PARP inhibitors in hereditary breast and ovarian cancer and other cancers: A review.


There has been a paradigm shift in the management of cancer, with the immense progress in cancer genomics. More and more targeted therapies are becoming available by the day and personalized medicine is becoming popular with specific drugs being designed for selected subgroups of patients. One such new class of targeted drugs in the armamentarium is Poly ADP Ribose Polymerase (PARP) inhibitors (PARPi), which inhibit the enzyme PARP, thus interfering with DNA repair. This strategy utilizes a pre-existing genomic lesion in tumors with homologous recombination repair defects (including BRCA mutations), weakening tumor cells further by blocking the alternate pathway of DNA repair. In this review, we discuss in detail, the evolution, genetics, mechanism of action, mechanism of resistance, indications of use of PARP inhibitors, as well as combination with other agents and future directions.
Authors: Mehta Prashant , Bothra Sneha J ,

Reference:

  1. ncbi.nlm.nih.gov. [Last access 2021/10/23].

Related products :

Catalog number Product name Quantity
Ovary - OVC961 Ovarian cancer array consists of duplicated 36 cases covering all the common types of ovarian cancer and 12 cases of normal and other non_malignant ovarian tissues. 1.5mm
Ovary - OVC1501 Ovarian cancer array consists of duplicated 70 cases covering all the common types of ovarian cancer and 5 cases of normal and other non_malignant ovarian tissues. 1.1mm
OVC2281 Hidensity ovarian cancer tissue array containing 8 cases of normal_benign conditions and 220 cases of cancers with grading and TNM staging data, 228 cases_228 cores
OVC2281 Hidensity ovarian cancer tissue array containing 8 cases of normal_benign conditions and 220 cases of cancers with grading and TNM staging data, 228 cases_228 cores; ihc H&E, IHC anti-Cytokeratin
15-288-21183 Breast and ovarian cancer susceptibility protein splice variant - Polyclonal 0.1 mg